Merrimack Pharma (MACK) – Trading Halts
-
Merrimack Pharma (MACK) to Resume Trading at 7:50 am ET
-
Merrimack Pharma (MACK) Phase 2 Trial of MM-141 in Front-Line Metastatic Pancreatic Cancer Did Not Meet Its Primary or Secondary Endpoints
-
-
-
-
-
-
-
-
-
Back to MACK Stock Lookup